Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, China.
BMC Med Genomics. 2022 Jul 8;15(1):152. doi: 10.1186/s12920-022-01271-3.
To investigate the genetic causes of hearing loss in patients with enlarged vestibular aqueduct (EVA), the SLC26A4-related genotypes and phenotypes were analyzed. SLC26A4 gene is closely associated with EVA and its homozygous mutations or compound heterozygous mutations may cause deafness and strongly affect quality of life.
The patients who came to our hospital for hearing test and accompanied by bilateral hearing abnormalities were collected for fifteen deafness-related gene mutations detection. Those who are positive will be verified by Sanger sequencing, combined with family history, hearing test, and computerized tomography (CT) of the temporal bone, aiming to diagnose the enlarged vestibular aqueducts. Whole-exome sequencing were performed when necessary.
Our patient failed hearing screening on both sides twice, and EVA (> 1.5 mm) was diagnosed by CT. This study has identified a novel missense mutation in the SLC26A4 gene, c.2069T>A, which in compound heterozygosity with c.1174A>T is likely to be the cause of hearing loss. The novel heterozygous c.2069T>A mutation of SLC26A4 gene has been submitted to Clinvar with Variation ID 1,048,780.
Our findings expand the gene mutation spectrum of SLC26A4 and provide additional knowledge for diagnosis and genetic counseling associated with EVA-induced hearing loss.
为了研究伴有前庭水管扩大(EVA)的患者的听力损失的遗传原因,分析了 SLC26A4 相关基因型和表型。SLC26A4 基因与 EVA 密切相关,其纯合突变或复合杂合突变可能导致耳聋,并严重影响生活质量。
收集了 15 名耳聋相关基因突变检测来我院进行听力测试并伴有双侧听力异常的患者。阳性者将通过 Sanger 测序进行验证,并结合家族史、听力测试和颞骨 CT,以诊断前庭水管扩大。必要时进行全外显子组测序。
我们的患者两次双侧听力筛查均未通过,CT 诊断为 EVA(>1.5mm)。本研究在 SLC26A4 基因中发现了一个新的错义突变 c.2069T>A,该突变与 c.1174A>T 复合杂合可能是导致听力损失的原因。SLC26A4 基因的新杂合 c.2069T>A 突变已被提交到 Clinvar,变异 ID 为 1,048,780。
我们的发现扩展了 SLC26A4 的基因突变谱,并为与 EVA 引起的听力损失相关的诊断和遗传咨询提供了额外的知识。